Inhibitors of the epidermal growth factor receptor in apple juice extract

Area of Science:

• Oncology
• Nutritional Science
• Biochemistry

Background:

• Colon cancer cell proliferation is regulated by the epidermal growth factor receptor (EGFR) signaling cascade.
• Polyphenols are plant-derived compounds with potential health benefits.
• Apple juice is a common consumer beverage containing various polyphenols.

Purpose of the Study:

• To investigate the in vitro effects of a polyphenol-rich apple juice extract on human colon cancer cell growth.
• To determine if the extract inhibits EGFR signaling in HT29 colon cancer cells.
• To identify specific apple juice constituents responsible for EGFR inhibition.

Main Methods:

• In vitro studies using the human colon cancer cell line HT29.
• Assessing the inhibitory effects of apple juice extract on EGFR protein tyrosine kinase activity.
• Analyzing the impact of the extract on mitogen-activated protein kinase (MAPK) signaling cascade.
• Identifying and quantifying key polyphenol compounds in the apple juice extract.

Main Results:

• The polyphenol-rich apple juice extract potently inhibited HT29 cell growth.
• The extract effectively inhibited EGFR protein tyrosine kinase activity and downstream MAPK signaling.
• Identified compounds like proanthocyanidins B1/B2 and quercetin glycosides showed EGFR-inhibitory properties.
• A synthetic mixture of known compounds exhibited only marginal EGFR inhibition, suggesting the presence of unknown active constituents.

Conclusions:

• Polyphenol-rich apple juice extract demonstrates significant anti-proliferative effects on colon tumor cells.
• The extract's efficacy is linked to the inhibition of EGFR signaling pathways.
• The potent activity of the extract is likely due to unidentified compounds beyond currently known proanthocyanidins and quercetin glycosides.